✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Market AccessSupply ChainEuropean MedicineCorporate ConsolidationPatient Access Why This MattersCorporate consolidation in European medical cannabis...
Tilray Brands acquires Lyphe Group, expanding UK medical cannabis footprint | StratCann
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Market AccessUk PolicyCorporate ConsolidationTreatment ContinuityInternational Markets Why This MattersConsolidation in medical cannabis markets affects...